STAMFORD, Conn., Dec. 17, 2024 /PRNewswire/ -- Neuvotion, Inc. is an early-stage medical device company developing AI-driven neuromodulation technologies and products…
Secondary analysis of a randomized, placebo-controlled study of 1,000+ participants indicated that FDA-authorized RelieVRx® yielded clinically meaningful pain intensity and pain…
A 1,100-Mile Journey Across Borders to Save Lives Through Organ DonationNote: A video accompanying this press release shares Scott's inspiring…
Dr. Gibson joining Lexaria's new scientific advisor board KELOWNA, BC / ACCESSWIRE / December 17, 2024 / Lexaria Bioscience Corp.…
Strategic agreements set the stage for further global adoption of portable MR brain imaging technology, fueling expansion plans for 2025.GUILFORD,…
Strategic agreements set the stage for further global adoption of portable MR brain imaging technology, fueling expansion plans for 2025.GUILFORD,…
ROCHESTER, N.Y., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX) (“Vaccinex” or the “Company”), a clinical-stage biotechnology company…
Company’s Exclusive Distribution Agreement with Zimmer Biomet included $3.0 Million Upfront Payment: Expected to Drive Revenue and Expand Margins Significantly…
FDA is expected to assign a Prescription Drug User Fee Act (PDUFA) target action date and announce whether Priority Review…
Single intrathecal dose of Rhenium (186Re) Obisbemeda delivers favorable responses in cerebrospinal fluid circulating tumor cell count, imaging, and clinical…